Company: TELO
Filing Date: 2025-02-14
Form Type: S-3
Source: 0001493152-25-006943
Chunk: 24

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-14
Form: S-3
Chunk 24
---
div>

We incorporate by reference the documents listed below and any future filings we make with the SEC under Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act (i) after the date of the Form S-3 with respect to securities offered by this prospectus and prior to the effectiveness of such registration statement and (ii) after the date of this prospectus and before the end of the offering of the securities pursuant to this prospectus:

| ● 
 ● | Our                                                                                                                            
 Annual Report on Form                                                                                                          
 10-K for the fiscal year ended December 31, 2024, filed with the SEC on February 4, 2025;                                      
 Our                                                                                                                            
 Current Reports on Form 8-K filed with the SEC on January                                                                      
 7, 2025 and January                                                                                                            
 28, 2025; and                                                                                                                  |
|:--|:-------------------------------------------------------------------------------------------------------------------------------|
| ● | The                                                                                                                            
 description of our common stock in Exhibit                                                                                     
 4.4 of our Form 10-K filed on February 4, 2025, including any other amendment or report filed for the purpose of updating such 
 description.                                                                                                                   |

Notwithstanding the foregoing, documents or portions thereof containing information furnished under Items 2.02 and 7.01 of any Current Report on Form 8-K, including the related exhibits under Item 9.01, are not incorporated by reference in this prospectus.

You should rely only on the information incorporated by reference or provided in this prospectus. We have not authorized anyone else to provide you with different information. Any statement contained in a document incorporated by reference into this prospectus will be deemed to be modified or superseded for the purposes of this prospectus to the extent that a later statement contained in this prospectus or in any other document incorporated by reference into this prospectus modifies or supersedes the earlier statement. Any statement so modified or superseded will not be deemed, except as so modified or superseded, to constitute a part of this prospectus. You should not assume that the information in this prospectus is accurate as of any date other than the date of this prospectus or the date of the documents incorporated by reference in this prospectus.

We will provide you with a copy of any information that we incorporate by reference into this prospectus or the registration statement that contains this prospectus, at no cost, by writing or calling us. Requests for such materials should be directed to:

<div align